Coherus Oncology (CHRS) Income from Discontinued Operations (2024 - 2026)
Coherus Oncology (CHRS) posted Income from Discontinued Operations of $12.72 million for Q2 2026, down 96.3% from $342.63 million a year earlier.
Powered by 
Analysis
Coherus Oncology (CHRS) Income from Discontinued Operations (2024 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Income from Discontinued Operations at Coherus Oncology was $29.01 million, down 92.1% year-over-year; for FY2025, it came in at $351.15 million, up 44.0% from FY2024.
- In prior years, Coherus Oncology's Income from Discontinued Operations was $243.9 million in FY2024.
- Quarterly Income from Discontinued Operations has run from a low of -$9.17 million in Q1 2025 to a high of $342.63 million in Q2 2025 over five years.
- According to Business Quant data, Income from Discontinued Operations for the three prior quarters was -$1.39 million (Q1 2026), $8.7 million (Q4 2025) and $8.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | - |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | - |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | - |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | - |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 8.00 Mn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 12.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.72 Mn |
| Mar 31, 2026 | -1.39 Mn |
| Dec 31, 2025 | 8.70 Mn |
| Sep 30, 2025 | 8.99 Mn |
| Jun 30, 2025 | 342.63 Mn |
| Mar 31, 2025 | -9.17 Mn |
| Dec 31, 2024 | -4.60 Mn |
| Sep 30, 2024 | 36.85 Mn |
| Jun 30, 2024 | 41.93 Mn |
| Mar 31, 2024 | 170.91 Mn |
API Access
Coherus Oncology Income from Discontinued Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-discontinued-operations", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();